Such beneficial effects have also been demonstrated in animal models of CKD in which systemic bolus supplementation of soluble klotho protein has led to attenuation of CKD progression without any major adverse effects, although it is unclear whether such a therapeutic approach is applicable to clinical practice [26, 27]. The gene discussed is KL; the disease is chronic kidney disease.